|
Name |
Fusaricidin B
|
Molecular Formula | C42H76N10O11 | |
IUPAC Name* |
N-[(3R,6R,9R,12S,15R,18S,19R)-6-(3-amino-3-oxopropyl)-9-[(1R)-1-hydroxyethyl]-3,19-dimethyl-2,5,8,11,14,17-hexaoxo-12,15-di(propan-2-yl)-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl]-15-(diaminomethylideneamino)-3-hydroxypentadecanamide
|
|
SMILES |
C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)O1)C)CCC(=O)N)[C@@H](C)O)C(C)C)C(C)C)NC(=O)CC(CCCCCCCCCCCCN=C(N)N)O
|
|
InChI |
InChI=1S/C42H76N10O11/c1-23(2)32-37(58)50-33(24(3)4)38(59)52-34(26(6)53)39(60)48-29(19-20-30(43)55)36(57)47-25(5)41(62)63-27(7)35(40(61)51-32)49-31(56)22-28(54)18-16-14-12-10-8-9-11-13-15-17-21-46-42(44)45/h23-29,32-35,53-54H,8-22H2,1-7H3,(H2,43,55)(H,47,57)(H,48,60)(H,49,56)(H,50,58)(H,51,61)(H,52,59)(H4,44,45,46)/t25-,26-,27-,28?,29-,32-,33+,34-,35+/m1/s1
|
|
InChIKey |
WDNFMLNXGKOBJN-IOGIGVIJSA-N
|
|
Synonyms |
Fusaricidin B; N-[(3R,6R,9R,12S,15R,18S,19R)-6-(3-Amino-3-oxopropyl)-9-[(1R)-1-hydroxyethyl]-3,19-dimethyl-2,5,8,11,14,17-hexaoxo-12,15-di(propan-2-yl)-1-oxa-4,7,10,13,16-pentazacyclononadec-18-yl]-15-(diaminomethylideneamino)-3-hydroxypentadecanamide; SCHEMBL630322
|
|
CAS | NA | |
PubChem CID | 10748277 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 897.1 | ALogp: | 2.7 |
HBD: | 11 | HBA: | 12 |
Rotatable Bonds: | 22 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 349.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 63 | QED Weighted: | 0.029 |
Caco-2 Permeability: | -5.813 | MDCK Permeability: | 0.00005040 |
Pgp-inhibitor: | 0.619 | Pgp-substrate: | 1 |
Human Intestinal Absorption (HIA): | 0.85 | 20% Bioavailability (F20%): | 0.991 |
30% Bioavailability (F30%): | 0.995 |
Blood-Brain-Barrier Penetration (BBB): | 0.043 | Plasma Protein Binding (PPB): | 71.54% |
Volume Distribution (VD): | 0.478 | Fu: | 19.42% |
CYP1A2-inhibitor: | 0 | CYP1A2-substrate: | 0.007 |
CYP2C19-inhibitor: | 0.021 | CYP2C19-substrate: | 0.034 |
CYP2C9-inhibitor: | 0.065 | CYP2C9-substrate: | 0.003 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.032 |
CYP3A4-inhibitor: | 0.078 | CYP3A4-substrate: | 0.049 |
Clearance (CL): | 2.937 | Half-life (T1/2): | 0.377 |
hERG Blockers: | 0.036 | Human Hepatotoxicity (H-HT): | 0.959 |
Drug-inuced Liver Injury (DILI): | 0.055 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.003 | Maximum Recommended Daily Dose: | 0.059 |
Skin Sensitization: | 0.042 | Carcinogencity: | 0.005 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.002 |
Respiratory Toxicity: | 0.007 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002406 | 0.936 | D0K7NQ | 0.354 | ||||
ENC003684 | 0.806 | D00ZCN | 0.339 | ||||
ENC003716 | 0.764 | D09OOV | 0.331 | ||||
ENC005275 | 0.518 | D02SBQ | 0.326 | ||||
ENC003950 | 0.504 | D07FEC | 0.314 | ||||
ENC005272 | 0.493 | D0D8XY | 0.310 | ||||
ENC005273 | 0.491 | D05HPI | 0.310 | ||||
ENC005274 | 0.466 | D0M3FJ | 0.309 | ||||
ENC005271 | 0.451 | D08FJL | 0.295 | ||||
ENC001983 | 0.427 | D0J7XL | 0.291 |